CN102512523A - Medicine for treating rheumatoid arthritis - Google Patents
Medicine for treating rheumatoid arthritis Download PDFInfo
- Publication number
- CN102512523A CN102512523A CN201110454403XA CN201110454403A CN102512523A CN 102512523 A CN102512523 A CN 102512523A CN 201110454403X A CN201110454403X A CN 201110454403XA CN 201110454403 A CN201110454403 A CN 201110454403A CN 102512523 A CN102512523 A CN 102512523A
- Authority
- CN
- China
- Prior art keywords
- medicine
- rheumatoid arthritis
- treating
- medicinal powder
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A medicine for treating rheumatoid arthritis is prepared by uniformly mixing Cibotium barometz, Scorpion, Eupolyphaga, anise, Gentiana macrophylla, Radix Saposhnikoviae, Notopterygium, peach kernel and safflower which are carefully selected and washed by water, crushing the mixture into 100-120-mesh medicinal powder, disinfecting and sterilizing the medicinal powder, and preparing the medicinal powder into a water pill product by using a bonding agent according to a conventional method. The medicine for treating the rheumatoid arthritis has the effects of expelling wind, dredging meridians, promoting blood circulation, warming menstruation, expelling cold, nourishing bones and tonifying Yang, has a good effect on treating the rheumatoid arthritis and has no toxic side effect.
Description
Technical field
The present invention relates to a kind of medicine of treating rheumatic arthritis, especially relating to a kind of is the medicine of the treatment rheumatic arthritis of crude drug preparation with Chinese medicine.
Background technology
Rheumatic arthritis is a kind of common acute or chronic ICT.Can show effect repeatedly and involve heart.Clinical miserable with joint and muscle the. fugitive, heavily work, pain is characteristic.Belong to allergic disease.Be one of main performance of rheumatic fever, how with febris acuta and arthralgia onset.Onset is early stage how similar with anemofrigid cold, is difficult for being paid attention to by people, mainly shows as waist and lower limb and sends out cold, aversion to wind, pain; The chance cold rnning is acute, and activity is stretched pain in the wrong not freely; Like untimely treatment; How to the later stage joint deformity, pain unbearably and cause the disease of heart kidney is in the misery patient for a long time.
Anti-inflammation analgesic, hormone medicine are used in the treatment of rheumatic arthritis more, but can not be effected a radical cure, and take said medicine for a long time, side effect is big at present.
Summary of the invention
The purpose of this invention is to provide a kind of is the medicine of the treatment rheumatic arthritis of crude drug preparation with Chinese medicine, this medicine with dispelling wind and removing obstruction in the collateral, invigorate blood circulation, dispelling cold by warming the meridian, the tonifying YANG of benefit bone be the principle treatment, therapeutic effect is good, expense is low.
Medicine of the present invention is that crude drug prepares by following parts by weight of traditional Chinese medicines:
Rhizoma Cibotii 5～7 Scorpios 5～7 Eupolyphaga Seu Steleophagas 5～7 Fructus Anisi Stellatis 4～8 Radix Gentianae Macrophyllae 5～8
Windproof 5～7 Rhizoma Et Radix Notopterygiis, 4～7 Semen Persicaes, 5～7 Flos Carthamis 4～7.
The medicine of above-mentioned each component can be processed said peroral dosage form on any pharmaceuticss such as tablet, pill, powder, capsule, and the preferred dosage form of the present invention is a water pill.
The concrete method for preparing of medicine water pill of the present invention agent is: said medicine by said parts by weight mix homogeneously, is ground into 100～120 purpose medicated powder, and sterilization uses binding agent to make the water pill product by conventional method.
In the prescription of the present invention, Rhizoma Cibotii invigorating the liver and kidney, bone and muscle strengthening, wind-damp dispelling; The active blood stasis dispelling of Scorpio, the endogenous wind stopping relieving convulsion; The Eupolyphaga Seu Steleophaga removing blood stasis; The Fructus Anisi Stellati dispersing cold for relieving pain; Radix Gentianae Macrophyllae wind-damp dispelling, Shujin network; Windproof expelling wind and removing dampness; Notopterygium wind dispelling blood stasis dispelling, pain relieving; Semen Persicae blood circulation promoting and blood stasis dispelling, pain relieving; Flos Carthami blood circulation promoting and blood stasis dispelling, pain relieving.All medicines share, and can play dispelling wind and removing obstruction in the collateral, invigorate blood circulation, the effect of dispelling cold by warming the meridian, the tonifying YANG of benefit bone, and are evident in efficacy to treatment rheumatic arthritis, and cheap.
For further investigating the clinical efficacy of Drug therapy rheumatic arthritis of the present invention, select 63 routine rheumatic arthritis patients to carry out clinical observation on the therapeutic effect.
Be divided into treatment group and matched group to 63 routine patients, 30 people are organized in treatment, matched group 33 people.
All case is all according to the diagnosis basis in " new Chinese medicine clinical research guideline (first volume) ":
(1) clinical manifestation: the streptococcal infection medical history is arranged more; Acute stage, can have multiple and the the. fugitive joint aches, mostly occurs in big joint, can be with redness pain or tuberosity or erythema; Chronic phase, can only be felt joint aches;
(2) laboratory examination: anti-" O " is more than 1:500; Or erythrocyte sedimentation rate speeds; Or antistreptokinase surpasses more than 80 units; Or antihyaluronidase is more than 128 units; Or C reflection protein positive;
(3) X-ray film does not have the sclerotin damage.
Be diagnosed as rheumatic arthritis.
Therapeutic Method
Matched group adopts ibuprofen, every day 1 time, one time 2;
The treatment group adopts water pill drug form of the present invention, every day 2 times, each 10 grams.
Before and after the treatment, treatment group and the matched group patient chamber of experimentizing each parameter of inspection are seen table 1:
The variation of each parameter before and after the table 1 rheumatic arthritis patient treatment
Criterion of therapeutical effect
Criterion of therapeutical effect with reference to " new Chinese medicine clinical research guideline (first volume) ".Cure: the arthralgia of getting involved after the treatment disappears, and function of joint is improved or recovered normal, and it is normal that erythrocyte sedimentation rate, rheumatoid factor have been recovered; Produce effects: the arthralgia of getting involved is clearly better or disappears, and erythrocyte sedimentation rate, rheumatoid factor titre reduce, or has recovered normal, but arthroncus does not disappear as yet; Effectively: the arthralgia of getting involved after the treatment or swell and ache and take a favorable turn; Invalid: with compare each side and do not have progress before the treatment.
Two groups of case treatment back curative effect comparative results are seen table 2.
Table 2 liang group case treatment back curative effect relatively
| Group | The example number | Cure n (%) | Effective n (%) | Invalid n (%) | Total effective rate n (%) |
| Matched group | 33 | 11（33.3） | 14（42.5） | ?8（24.2） | 25（75.8） |
| The treatment group | 30 | 17（56.7） | 9（30） | 4（13.3） | 26（86.7） |
The specific embodiment
Embodiment 1
Get Rhizoma Cibotii 50g, Scorpio 50g, Eupolyphaga Seu Steleophaga 50g, Fructus Anisi Stellati 40g, Radix Gentianae Macrophyllae 50g, windproof 50g, Rhizoma Et Radix Notopterygii 40g, Semen Persicae 50g, Flos Carthami 40g mix homogeneously selected, that clear water is cleaned; Be ground into 100～120 medicated powder, sterilization uses binding agent to make the water pill product by conventional method.
Embodiment 2
Get Rhizoma Cibotii 70g, Scorpio 70g, Eupolyphaga Seu Steleophaga 70g, Fructus Anisi Stellati 80g, Radix Gentianae Macrophyllae 80g, windproof 70g, Rhizoma Et Radix Notopterygii 70g, Semen Persicae 70g, Flos Carthami 70g mix homogeneously selected, that clear water is cleaned, be ground into 100～120 medicated powder, sterilization makes the powder product.
Claims (2)
1. medicine of treating rheumatic arthritis is that crude drug prepares by the Chinese medicine of following portions by weight:
Rhizoma Cibotii 5～7 Scorpios 5～7 Eupolyphaga Seu Steleophagas 5～7
Fructus Anisi Stellati 4～8 Radix Gentianae Macrophyllae 5～8 windproof 5～7
Rhizoma Et Radix Notopterygii 4～7 Semen Persicaes 5～7 Flos Carthamis 4～7.
2. the medicine of treatment rheumatic arthritis according to claim 1 is characterized in that said medicine is processed the water pill dosage form.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201110454403XA CN102512523A (en) | 2011-12-30 | 2011-12-30 | Medicine for treating rheumatoid arthritis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201110454403XA CN102512523A (en) | 2011-12-30 | 2011-12-30 | Medicine for treating rheumatoid arthritis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102512523A true CN102512523A (en) | 2012-06-27 |
Family
ID=46283776
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201110454403XA Pending CN102512523A (en) | 2011-12-30 | 2011-12-30 | Medicine for treating rheumatoid arthritis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102512523A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102764350A (en) * | 2012-07-17 | 2012-11-07 | 遵义臻坤中草医药研究所 | Chinese medicinal composition for treating rheumatoid bone diseases and arthralgia |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101259178A (en) * | 2008-04-10 | 2008-09-10 | 北京万寿通医药科技有限公司 | Chinese medicine preparation for treating rheumatoid arthritis |
| CN101683400A (en) * | 2008-09-22 | 2010-03-31 | 赵保云 | Preparation method of pill for treating three kinds of spinal arthralgia |
-
2011
- 2011-12-30 CN CN201110454403XA patent/CN102512523A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101259178A (en) * | 2008-04-10 | 2008-09-10 | 北京万寿通医药科技有限公司 | Chinese medicine preparation for treating rheumatoid arthritis |
| CN101683400A (en) * | 2008-09-22 | 2010-03-31 | 赵保云 | Preparation method of pill for treating three kinds of spinal arthralgia |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102764350A (en) * | 2012-07-17 | 2012-11-07 | 遵义臻坤中草医药研究所 | Chinese medicinal composition for treating rheumatoid bone diseases and arthralgia |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101214286B (en) | Chinese medicine white spirit preparations for effectively treating rheumatic pain diseases | |
| CN101491572A (en) | Medicine for treating calculus and preparation method thereof | |
| CN102258658B (en) | Plaster for invigorating blood circulation and relieving pain | |
| CN100571770C (en) | A kind of Chinese medicine cutaneous permeable agent | |
| CN101972464B (en) | Traditional Chinese medicine composition for treating rheumatoid arthritis and preparation method thereof | |
| CN102406766B (en) | Traditional Chinese medicine composition for treating bone fracture and application thereof | |
| CN103211886A (en) | Medicament for treating rheumatic arthritis | |
| CN1389255A (en) | Composite Chinese medicine for treating rheumarthritis and rheumatoid arthritis | |
| CN1074676C (en) | Medicine for treating rheumatic arthritis and hyperosteogeny and preparing process thereof | |
| CN101530516B (en) | Chinese medicament for treating appendicitis | |
| CN102512523A (en) | Medicine for treating rheumatoid arthritis | |
| CN1927371A (en) | Blood flow promoting pellet and preparing process thereof | |
| CN102430096B (en) | Medicament for treating rheumatic or rheumatoid diseases | |
| CN102631435A (en) | Medicament for treating rheumatoid arthritis | |
| CN103893436B (en) | A kind of externally applied drug for treating rheumatism | |
| CN103599185B (en) | A kind of Chinese medicine composition being used for the treatment of headache | |
| CN102727831B (en) | Traditional Chinese medicine for treating cholelithiasis | |
| CN102579617A (en) | Traditional Chinese medicine capsule for treating chronic neck, shoulder, waist and leg pains and processing method of same | |
| CN101954043A (en) | Medicament for treating hyperosteogeny and preparation method thereof | |
| CN101890076B (en) | Traditional Chinese medicine oral preparation for treating sores and ulcers | |
| CN102225125B (en) | Externally applied traditional Chinese medicine composite for treating joint pain caused by rheumatoid arthritis and preparation method thereof | |
| CN104225056A (en) | Drug for treating rheumatic arthritis | |
| CN1589859A (en) | Chinese medicinal composition for treating rheumatism rheumatoid arthritis and osteosis | |
| CN102727699A (en) | Externally used drug for treating rheumatic arthritis | |
| CN105641586A (en) | Fengtongning preparation and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20120627 |